Cargando…
Serum amyloid A (SAA) and Interleukin-6 (IL-6) as the potential biomarkers for gastric cancer
To explore serum amyloid A (SAA) and interleukin-6 (IL-6) as potential diagnostic biomarkers for gastric cancer (GCa) and the application value of the combined diagnosis of SAA, IL6, and Cancer embryonic antigen. Serum samples were collected before the initial surgery from 159 patients comprising sa...
Autores principales: | Hou, Yongwang, Zhao, Weidong, Yang, Zhicong, Zhang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622617/ https://www.ncbi.nlm.nih.gov/pubmed/36316846 http://dx.doi.org/10.1097/MD.0000000000031514 |
Ejemplares similares
-
Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern
por: Kim, Hyoung Woo, et al.
Publicado: (2017) -
The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection
por: Sheng, Tao, et al.
Publicado: (2015) -
The correlation of serum sirt6 with clinical outcome and prognosis in patients with gastric cancer
por: Li, Danyang, et al.
Publicado: (2022) -
Interleukin-6 gene polymorphisms and susceptibility to liver diseases: A meta-analysis
por: Wang, Xuehan, et al.
Publicado: (2019) -
Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis
por: An, Pei-Pei, et al.
Publicado: (2020)